Viewing StudyNCT00796666



Ignite Creation Date: 2024-05-05 @ 8:04 PM
Last Modification Date: 2024-10-26 @ 9:58 AM
Study NCT ID: NCT00796666
Status: TERMINATED
Last Update Posted: 2015-03-24
First Post: 2008-11-20

Brief Title: Study Looking at Combination Therapy SitaxsentanSildenafil Vs Monotherapy Sitaxsentan Alone SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Pulmonary Hypertension
Pulmonary Arterial Hypertension
Keywords:
Name View
Sitaxsentan View
endothelin receptor antagonist ETRA View